Updated:
Walbert Capital Management
WALBERT CAPITAL MANAGEMENT, LLC is an SEC-registered investment adviser in NEW CANAAN, CT. The firm manages approximately $18 million in assets.
Walbert Capital Management
WALBERT CAPITAL MANAGEMENT, LLC is an SEC-registered investment adviser in NEW CANAAN, CT. The firm manages approximately $18 million in assets. It has 1 employee and 1 investment adviser.
General information
Firm type
Asset Manager
Year founded
2011
Location
Region
North America
Country
United States
City
New Canaan
Corporate office
Atlanta, GA, United States
Principals
Timothy Walbert
Founder & Chairman
Sector focus
Frequently asked questions
Who runs Walbert Capital Management, and what is his background?
Timothy Walbert is the Founder and Chairman. He previously served as chairman and CEO of Horizon Therapeutics, which he led from a near-bankrupt startup to a $27.8 billion acquisition by Amgen in 2023. Prior to Horizon, Walbert held senior commercial roles at Abbott, Merck, and Searle.
What is the source of capital for Walbert Capital Management's investments?
The firm deploys Timothy Walbert's personal capital, substantially augmented by the proceeds from Amgen's 2023 acquisition of Horizon Therapeutics. Walbert Capital Management does not raise outside funds or manage third-party capital.
What sectors and stages does Walbert Capital Management target?
The firm invests exclusively in life sciences and healthcare services, with a focus on biopharma, diagnostics, and specialty therapeutics. Its stage mandate ranges from seed-stage diagnostic platforms to pre-commercial biotechnology companies. Walbert typically takes a board seat in each investment.
Does Walbert Capital Management invest as an LP in venture funds?
No. The firm makes direct equity investments only and does not participate as a limited partner in external venture or growth-equity funds. Its model relies on concentrated positions and active board oversight rather than diversified fund commitments.
How is Walbert Capital Management related to Horizon Therapeutics?
Timothy Walbert founded Walbert Capital Management while serving as chairman and CEO of Horizon Therapeutics. The two entities were always legally and operationally distinct. Since Amgen acquired Horizon in 2023, Walbert Capital Management continues independently as Walbert's personal investment platform.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: